NGS Clinical Dx Firm Blueprint Genetics Raises Funds | GenomeWeb

NEW YORK (GenomeWeb) – Next-generation sequencing-based clinical diagnostics firm Blueprint Genetics today announced it has raised $3.9 million to fund its international expansion.

It is unclear if the $3.9 million figure is the amount the Finnish firm raised in the most recent financing round or if it is the total amount raised since its founding. On deadlinie, the company did not respond to a request for clarification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.